EMN vs RYTM · P/E 21, rev $9.38B vs rev $130.1M
Eastman Chemical Company (EMN) versus Rhythm Pharmaceuticals Inc (RYTM) — a side-by-side from cached financials, not a winner call.
Eastman Chemical Company (EMN) is a specialty chemicals company listed on US.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
Latest reported EMN revenue for 2024-12-31 was $9.38B. Net income was $908.0M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
EMN currently screens at market cap $8.21B and trailing P/E 20.8. RYTM currently screens at market cap $6.49B.
Not investment advice. Open the EMN and RYTM stock pages for the full models.
Not investment advice.